If you've spent years assuming acne was a hygiene problem, you've been operating under a misconception that affects millions. Hormonal acne isn't caused by not washing your face properly or eating greasy food. It's a medical condition driven by internal hormone signals that trigger your skin to produce excess oil, creating an environment where bacteria thrive, and inflammation develops.

For women especially, hormonal acne is frustratingly common. About half of all women with acne report that their breakouts worsen around their menstrual cycle. For others, acne emerges or worsens during pregnancy, after stopping birth control, or later in adulthood. And for those with PCOS (polycystic ovary syndrome), severe acne can be a persistent feature of the condition.

The good news: once you understand what's driving your acne, treatment becomes straightforward. Topical scrubs and spot treatments won't address the root cause. But hormonal medications, targeted lifestyle changes, and strategic skincare can deliver dramatic improvements within weeks to months.

What is Hormonal Acne, Really?

All acne develops through the same basic biological process. Within and around hair follicles, four things happen simultaneously. First, excess oil (sebum) gets produced. Second, skin cells shed abnormally and block the follicle. Third, bacteria (specifically a strain called Cutibacterium acnes) proliferate in this oily, blocked environment. Fourth, your immune system mounts an inflammatory response, causing the redness, swelling, and sometimes painful cysts you see.

The distinction with hormonal acne is what triggers step one: the excess oil production. In hormonal acne, the trigger is internal. Androgens (male hormones that both men and women have) directly stimulate sebaceous glands to produce more oil. When those hormonal signals are consistently elevated, or your skin is exquisitely sensitive to normal hormone fluctuations, you get acne.

This is why hormonal acne differs from acne caused by other factors. It's not a response to an external irritant. It's not medication-induced. It's not the result of ignoring your skincare routine. Your skin is responding perfectly appropriately to hormonal signals; the problem is the signal itself.

How Hormones Actually Trigger Acne

Understanding the mechanism helps explain why certain treatments work and why others don't.

Androgens (testosterone and dihydrotestosterone, or DHT) are the only hormones proven to increase sebum production. Here's how it works: when testosterone enters sebaceous gland cells, an enzyme called 5-alpha reductase converts it to DHT, the most potent form. DHT then binds to receptors inside oil-producing cells, essentially flipping a switch that tells them to produce more lipids.

This process doesn't happen uniformly across your skin. The enzyme 5-alpha reductase is present at significantly higher levels in facial sebaceous glands compared to other areas. This explains why acne is so face-dominant, particularly on the lower face and jawline, where the enzyme activity is highest.

During puberty, this process goes into overdrive. Testosterone can rise 10 to 20 times in boys and 5 to 10 times in girls, triggering sebum production to increase 2 to 4 fold. Add to this the rise in IGF-1 (insulin-like growth factor 1) that occurs during puberty, and you have a perfect storm. IGF-1 amplifies androgen effects in three ways: it stimulates additional androgen production, activates 5-alpha reductase for more DHT conversion, and directly stimulates oil-producing cells.

Critically, research shows that people with IGF-1 deficiency do not develop acne, even when exposed to androgens. This means IGF-1 is essential for hormone-driven acne. It's also why high-glycaemic foods, which spike your insulin and IGF-1 levels, can worsen acne.

Beyond just producing excess oil, androgens also amplify inflammation. They trigger sebaceous glands and immune cells to produce pro-inflammatory molecules (interleukins and cytokines), which intensify the immune response against bacteria and follicular damage. This is why hormonal acne tends to be more inflammatory than other types; you get more papules, pustules, and potentially cystic lesions rather than just comedones.

The Menstrual Cycle Connection

If you're a woman whose acne flares with your period, you've identified one of the clearest proofs that hormones are driving your acne.

Over the course of a menstrual cycle, hormone levels shift predictably. During the follicular phase (roughly the first two weeks), oestrogen gradually rises whilst testosterone remains relatively low. Acne typically improves during this phase.

During the luteal phase (the second half of your cycle), progesterone rises significantly. Here's where it gets interesting: progesterone doesn't directly increase sebum production the way androgens do. Instead, it increases your skin's sensitivity to androgens. The same amount of circulating androgen has a stronger effect on oil production when progesterone levels are elevated. Additionally, progesterone may promote abnormal skin cell shedding within follicles, contributing to blockage.

The data reflect this pattern clearly. About 44 to 56.7% of women with acne report perimenstrual flares. Of those, 58.5% experience worsening acne before their period, 35% during menstruation, and 6.5% after. Some women even break out exclusively during the luteal phase, with completely clear skin during the first half of their cycle. For these women, the monthly pattern is unmistakable proof that hormones are responsible.

Menstrual Acne Timing

Figure 1: Most menstrual acne flares occur in the week before the period begins, when progesterone is elevated, and skin sensitivity to androgens increases.

Who Is Most Affected?

Hormonal acne affects different populations differently. Understanding prevalence helps you recognise whether your acne fits the hormonal pattern.

Adolescents

80 to 90% of all teenagers experience acne at some stage. Of those, only about 15% have acne severe enough to seek medical treatment. Importantly, only 5% of females and 1% of males continue to experience acne past age 25. This tells us something reassuring: for the vast majority of people, adolescent hormonal acne is temporary. It naturally resolves as hormone levels stabilise and skin maturation occurs.

Women with Menstrual-Cycle Acne

44 to 56.7% of women who experience acne report cycle-related flares. Beyond those with obvious monthly patterns, 39.2% of women with difficult-to-treat (refractory) acne have abnormal menstrual patterns, suggesting an underlying hormonal imbalance.

Women with PCOS

This is where the connection between hormones and acne becomes especially clear. PCOS is an endocrine condition characterised by excess androgen production, insulin resistance, and irregular ovulation. About 49% of women with PCOS develop acne, making it one of the most common skin manifestations of the condition.

Here's what's striking: 37.3% of women with severe acne have PCOS. When researchers compare this to healthy controls (essentially 0%), the connection becomes undeniable. If you have severe acne accompanied by irregular periods, excess facial or body hair (hirsutism), or hair loss, hormonal investigation for PCOS is worth pursuing.

The prevalence varies by geography and age, though. PCOS acne is most common in adolescents (66% prevalence in those under 18) and varies from 76% in Oceania to 32% in Europe, suggesting genetic and environmental factors play a role.

Pregnancy and Postpartum

Many women develop acne or experience worsening acne for the first time during pregnancy, whilst others improve. Hormonal mechanisms aren't fully understood, but oestrogen may have mild anti-androgenic effects (helping some women), whilst progesterone increases skin sensitivity to androgens and inflammatory stimuli. After delivery, when hormone levels crash, postpartum acne flares are common.

Treatment Options: What Actually Works

The research on acne treatment is extensive and robust. Here's what delivers results for hormonal acne specifically.

Oral Contraceptives (Birth Control Pills)

For women with hormonal acne, combination birth control pills are often the first-line treatment. They work through multiple mechanisms: the oestrogen component suppresses androgen production and increases SHBG (a protein that binds free testosterone, making it inactive). The progestin component varies by formulation; some progestins have anti-androgenic activity, whilst others (levonorgestrel, norethindrone) are androgenic and can worsen acne.

The clinical data are clear. Acne decreased by 52.8 to 58.5% after 9 months of therapy in controlled trials. However, patience is essential. Results typically take 3 months (three cycles) to become apparent, with maximum benefit sometimes not achieved until a full year of use.

The FDA has approved three oral contraceptives specifically for acne treatment: Ortho Tri-Cyclen (contains norgestimate), Estrostep (variable dose norethindrone formulation), and Yaz/Yasmin (contains the anti-androgenic progestin drospirenone). Other formulations work, but these have the strongest evidence.

Spironolactone

This medication works differently from birth control. It's an anti-androgen that blocks androgen receptors directly, preventing DHT from activating sebaceous glands. It also increases SHBG levels, further reducing bioavailable androgens.

The efficacy is impressive. 75.5% of patients experienced reduction or complete clearance of facial acne, with even higher clearance rates for chest (84%) and back (80.2%) acne. For adolescent females, 80% reported improvement.

Typical dosing starts at 50 to 100 mg daily, often escalating to 100 to 200 mg. Starting at 100 mg daily is recommended as most patients tolerate it well, and it provides superior effectiveness compared to lower doses. Results take 3 to 8 months. Common side effects include lightheadedness, headache, and menstrual irregularities, though these are dose-dependent.

When spironolactone is combined with oral contraceptives, outcomes are even better. 85% of patients treating severe acne with a combination of oral contraceptive (ethinyl oestradiol/drospirenone) plus spironolactone 100 mg daily were entirely clear or had excellent improvement. The combination also reduces menstrual side effects significantly.

Combination Therapy: Birth Control Plus Spironolactone

The evidence strongly supports combining hormonal treatments over using either alone. When two hormonal mechanisms attack androgens simultaneously (birth control suppresses androgen production whilst spironolactone blocks androgen receptors), the results are superior.

This approach is especially valuable for women with severe hormonal acne. Beyond efficacy, the combination is safe. Contrary to concerns, spironolactone combined with oral contraceptives does not cause significant potassium elevation.

Isotretinoin (Accutane): The Nuclear Option

For severe acne unresponsive to other treatments, isotretinoin is the gold standard. It's the most effective acne treatment available, period.

97.4% of patients reported acne improvement at 12 months follow-up, with most people achieving dramatic results. It reduces inflammatory lesions by more than 90%, and some patients remain virtually clear of acne even at 10-year follow-up. About 4 months of therapy achieves 85% clinical improvement for most patients.

However, isotretinoin comes with significant caveats. It's teratogenic (causes severe birth defects) and is absolutely contraindicated in pregnancy. In the US, it's part of the iPLEDGE programme, which mandates two forms of contraception and monthly pregnancy tests. Nearly 100% of patients develop cheilitis (severe lip dryness) and xerosis (dry skin), and there are rare reports of depression and suicidal thoughts. All patients require close monitoring.

This medication is reserved for moderate to severe acne, particularly nodulocystic acne or cases with significant scarring risk. The potential for long-term clearance makes it worthwhile for those appropriate candidates, but it's not first-line.

Topical Retinoids

These vitamin A derivatives are the workhorse of acne treatment. They work by unclogging pores, reducing microcomedone formation, and exerting anti-inflammatory effects. They're also genuinely preventative, stopping new acne before it forms.

The efficacy varies by specific retinoid and degree of severity. About 73 to 74% of people achieve at least 50% improvement with topical retinoids. However, only about 17 to 24% achieve clinically significant improvement (which researchers define more stringently). Results take 1 to 3 months.

Topical retinoids are the first-line treatment for mild to moderate acne and work well in combination with hormonal therapy. Common side effects include redness, peeling, and dryness, which often improve with continued use. They increase sun sensitivity, so daily SPF 30+ sunscreen is essential.

Treatment Efficacy Comparison

Figure 2: Efficacy comparison across major hormonal acne treatments. Isotretinoin is most effective; combination therapy (OCP plus spironolactone) achieves superior results compared to either monotherapy. Data from clinical trials and efficacy studies.

When to Expect Results

One of the most common reasons people abandon effective acne treatments is unrealistic expectations about the timeline.

Oral contraceptives take 3 months to show lesion count reduction, with full benefits potentially taking up to a year. Spironolactone similarly requires 3 to 8 months. Topical retinoids show response in 1 to 3 months. Isotretinoin is relatively fast at 4 months for 85% improvement.

But here's what the data reveals about real-world treatment: 25% of patients discontinue treatment within approximately 3 months, 50% by 5 months, and 75% by 8 months. Many stop right before treatment would have delivered results.

If hormonal therapy has been prescribed, discuss realistic timelines with your dermatologist. Plan to stay on treatment for at least 3 to 8 months before assessing effectiveness. Early discontinuation almost guarantees failure.

Lifestyle and Diet: What You Can Control

Whilst medication addresses the hormonal driver, lifestyle modifications can amplify results. The evidence for dietary impact on acne is strongest for a few specific factors.

High-Glycaemic Foods: Strong Evidence to Avoid

The research consistently shows that high glycaemic index and high glycaemic load foods are positively associated with acne severity. Here's why: when you consume foods that cause rapid blood sugar spikes (white bread, sugary cereals, refined carbohydrates, fizzy drinks), your body responds with increased insulin and IGF-1 production. Remember from earlier? IGF-1 is the amplifier that makes hormones wreak havoc on your sebaceous glands.

The recommendation is straightforward: choose low-glycaemic foods (glycaemic index less than 55) like whole grains, legumes, and most vegetables. Avoid high-glycaemic foods (glycaemic index greater than 70) like white bread, sugary cereals, and refined carbs. This change alone can produce noticeable improvement in acne severity when combined with other modifications.

Dairy Products: Moderate Evidence to Reduce

A large meta-analysis of 78,529 people found that all types of cow's milk increase acne risk. The findings were consistent across different dairy forms.

• Any dairy: 1.25 times increased acne risk
• Low-fat/skim milk: 1.32 times increased risk (the worst offender)
• Full-fat milk: 1.22 times increased risk
• Cheese: 1.22 times increased risk
• Yoghurt: 1.36 times increased risk (equally problematic to low-fat milk)

Why does dairy trigger acne? Milk contains whey proteins that stimulate insulin production, plus naturally occurring hormones. Surprisingly, low-fat milk is worse than full-fat milk, possibly because processing removes protective fat whilst leaving the problematic proteins intact.

The evidence is observational, not causal, and individual response varies enormously. But if you're prone to acne, trying a 2 to 4 week elimination of dairy is worth testing. If your breakouts improve, you've identified a trigger. If nothing changes, you can safely reintroduce it.

Diet and Lifestyle Impact on Acne Severity

Figure 3: Relative risk increase for dietary and lifestyle factors. Low-fat milk and yogurt show the highest acne risk increase, followed by high-glycaemic foods. Data from meta-analyses and clinical trials.

Chocolate: Moderate Evidence

Clinical trials show that chocolate consumption significantly increases acneiform lesions in acne-prone people within 4 to 7 days. Even 50 grammes daily of 85% cocoa chocolate (the "healthy" option) exacerbated acne in susceptible individuals.

The mechanism likely involves high sugar content (spiking IGF-1) and compounds that may influence inflammation. If your acne is active, avoiding or minimising chocolate during flares is reasonable. Testing a 2 to 4 week elimination can reveal whether you're personally sensitive.

Sleep Quality: Strong Evidence

Poor sleep quality is associated with increased acne severity in both adolescents and adults, and the relationship is bidirectional: bad sleep makes acne worse, and active acne disrupts sleep.

Why does sleep matter? Sleep deprivation increases cortisol (stress hormone) production, impairs immune function, increases systemic inflammation, and disrupts skin barrier recovery (which happens primarily during sleep). The correlation is so robust that one study found cognitive-behavioural therapy for insomnia improved both sleep quality and acne outcomes simultaneously.

The recommendation is straightforward: target 7 to 9 hours nightly with a consistent sleep schedule. Many people see acne improvement within 1 to 2 weeks of improved sleep; the effects compound over months.

Stress Management: Moderate to Strong Evidence

Stress significantly correlates with acne exacerbation. Here's the mechanism: elevated stress triggers cortisol production, which stimulates androgen synthesis. Stress also impairs immune function, allowing acne bacteria to proliferate, and increases systemic inflammation.

Effective evidence-based stress management includes exercise (even moderate activity reduces cortisol), meditation or mindfulness, adequate sleep, social support or therapy, and hobbies that genuinely relax you. When combined with other lifestyle changes, stress reduction typically produces noticeable acne improvement within 2 to 4 weeks.

Hormonal Acne Prevalence Across Populations

Figure 4: Prevalence of acne across different populations. Adolescent acne is nearly universal (80-90%), but most resolve by age 25 (only 5% of women and 1% of men continue past 25). PCOS-related acne is significantly higher (49% of PCOS patients), reflecting the androgen excess in this condition. Data from the NHS, population studies, and meta-analyses.

Exercise: Moderate Evidence

Observational data show that elite athletes (exercising 8+ hours weekly) had less acne than recreational athletes. Regular exercise improves skin moisture and barrier function whilst reducing stress cortisol levels.

The recommendation is 30 minutes of aerobic activity 4 to 5 times weekly, or strength training compatible with your acne treatment. Critically, shower or cleanse within 30 minutes after sweaty exercise, and change out of sweaty clothes. Sweat itself doesn't cause acne, but bacteria plus sweat in occluded pores do.

Exercise alone doesn't treat acne, but it supports overall skin health and provides stress reduction benefits.

Skincare: Gentle and Consistent Approach

Contrary to myth, over-cleaning doesn't prevent acne. In fact, harsh scrubbing, abrasive washcloths, and overuse of astringents damage your skin barrier and worsen inflammation.

The evidence-based skincare approach for acne-prone skin is straightforward:

• Cleanse twice daily (morning and evening) with a mild, non-comedogenic cleanser
• Use lukewarm water, not hot
• Apply cleanser gently with fingertips only; avoid scrubbing
• Moisturise twice daily after cleansing with a non-comedogenic, water-based moisturiser (even oily, acne-prone skin needs hydration)
• Use sunscreen SPF 30+ daily
• If using acne treatments, start low and build tolerance gradually

This sounds simple because it is. The goal is supporting your skin barrier function, not stripping it clean.

When to See a Dermatologist

Not all acne is hormonal, and not all hormonal acne presents the same way. See a dermatologist if:

• Your acne started or worsened after age 25
• Your acne flares cyclically with your menstrual period
• You have irregular periods or other signs of hormonal imbalance (excess facial or body hair, scalp hair loss)
• Your acne is severe or leaves scars
• Topical treatments and lifestyle changes haven't improved acne after 8 to 12 weeks
• Your acne is sudden and accompanied by other hormonal symptoms

A dermatologist can determine whether your acne is truly hormonally driven and which treatment approach is most appropriate for your situation and medical history.

The Practical Path Forward

The evidence suggests a phased approach works best.

Phase 1: Fundamentals (Weeks 1-4)

Start immediately with these high-impact changes. Get 7 to 9 hours of sleep nightly. Reduce high-glycaemic foods (cut out sugary drinks and refined carbohydrates). Establish a gentle skincare routine with twice-daily cleansing and daily moisturising. Begin stress management through exercise, meditation, or whatever genuinely reduces your stress.

Many people see measurable improvement within 2 to 4 weeks from sleep and stress management alone.

Phase 2: Dietary Refinement (Weeks 4-8)

If Phase 1 helps but doesn't fully clear your acne, try eliminating dairy for 2 to 4 weeks while monitoring breakouts. If you see improvement, maintain reduced dairy intake. If nothing changes, reintroduce it. Similarly, reduce chocolate if you notice a pattern between consumption and flares.

Increase omega-3 sources (fatty fish, flaxseeds, chia seeds, walnuts, legumes) as part of an anti-inflammatory diet. Add a variety of colourful fruits and vegetables.

Phase 3: Topical Treatments (Weeks 8+)

If needed, add over-the-counter acne treatments: benzoyl peroxide (2.5%), salicylic acid, or adapalene (a retinoid). Use daily SPF 30+ sunscreen. Apply moisturiser to counteract medication-related dryness.

Most acne responds to the combination of lifestyle modifications plus topical treatment within 6 to 8 weeks.

Phase 4: Professional Intervention (If Needed)

If acne persists despite 8 to 12 weeks of lifestyle changes and topical treatment, see a dermatologist. Options include prescription-strength retinoids, hormonal contraception, spironolactone, or isotretinoin for severe cases.

Treatment Timeline Overview

Figure 5: Expected timeline for major hormonal acne treatments. Isotretinoin works fastest (4 months to 85% improvement), whilst oral contraceptives require longer (up to 12 months for maximum benefit). Patience is essential; most treatments need 3-8 months for adequate assessment.

Multi-Phase Improvement Trajectory

Figure 6: Cumulative improvement through phased lifestyle and treatment approach. Phase 1 alone produces about 20% improvement; adding dietary changes (Phase 2) brings cumulative improvement to about 50%; incorporating topical treatments (Phase 3) typically achieves 90% total improvement.

The Bottom Line

Hormonal acne is a real medical condition, not a reflection of poor hygiene or personal failure. Once you understand the hormonal mechanism driving your acne, treatment becomes logical and often remarkably effective.

Most adolescent acne resolves naturally by the mid-20s. For those whose acne persists or emerges in adulthood, hormonal approaches like oral contraceptives or spironolactone (especially in combination) deliver impressive results. Severe cases respond dramatically to isotretinoin.

Equally important are the lifestyle factors completely within your control. Sleep, stress management, and dietary modifications (especially reducing high-glycaemic foods and testing dairy elimination) can meaningfully improve acne within weeks to months.

The key is patience. Effective acne treatments typically require 3 to 8 months to show full results. Many people abandon treatment too early. Combine pharmacological approaches with lifestyle modifications, set realistic timelines, and give treatment time to work. For most people, significant improvement is achievable.

Further Reading

Understanding Hormonal Acne Mechanisms

• Hormonal causes of acne - NHS
• Acne and hormones - Mayo Clinic
• Sex hormones and acne - PubMed

Hormonal Treatment Options

• Acne treatment overview - NHS
• Hormonal contraceptives for acne - Mayo Clinic
• Spironolactone for acne - PubMed

Diet and Acne

• Diet and acne research - PubMed
• Dairy and acne meta-analysis - PubMed
• Glycaemic index and acne - PubMed

Lifestyle Factors

• Sleep quality and acne - PubMed
• Stress and acne - PubMed
• Skincare for acne - American Academy of Dermatology

PCOS and Acne

• PCOS and acne - Mayo Clinic
• PCOS acne prevalence - PubMed
• PCOS management - Cleveland Clinic

References/Helpful Resources

1. National Institutes of Health and National Center for Biotechnology Information. Sex hormones and acne. PubMed. https://pubmed.ncbi.nlm.nih.gov/28274349/
2. NHS. Acne: causes [Internet]. [cited 2026 Apr 27]. Available from: https://www.nhs.uk/conditions/acne/causes/
3. NHS. Acne: treatment [Internet]. [cited 2026 Apr 27]. Available from: https://www.nhs.uk/conditions/acne/treatment/
4. Mayo Clinic. Acne: symptoms and causes [Internet]. [cited 2026 Apr 27]. Available from: https://www.mayoclinic.org/diseases-conditions/acne/symptoms-causes/syc-20368047
5. National Institutes of Health and National Center for Biotechnology Information. Hormonal profiles and prevalence of polycystic ovary syndrome in women with acne. PubMed. https://pubmed.ncbi.nlm.nih.gov/9164062/
6. National Institutes of Health and National Center for Biotechnology Information. Acne: hormonal concepts and therapy. PubMed. https://pubmed.ncbi.nlm.nih.gov/15556729/
7. National Institutes of Health and National Center for Biotechnology Information. Sex hormones and acne: State of the art. PubMed. https://pubmed.ncbi.nlm.nih.gov/33576151/
8. National Institutes of Health and National Center for Biotechnology Information. The cutaneous effects of androgens and androgen-mediated sebum production and their pathophysiologic and therapeutic importance in acne vulgaris. PubMed. https://pubmed.ncbi.nlm.nih.gov/38192024/
9. National Institutes of Health and National Center for Biotechnology Information. Acne and serum androgens during puberty. PubMed. https://pubmed.ncbi.nlm.nih.gov/131513/
10. National Institutes of Health and National Center for Biotechnology Information. Plasma androgenic activity in women with acne vulgaris and in healthy girls before, during, and after puberty. PubMed. https://pubmed.ncbi.nlm.nih.gov/6210470/
11. National Institutes of Health and National Center for Biotechnology Information. Adolescent acne: association to sex, puberty, testosterone. PubMed. https://pubmed.ncbi.nlm.nih.gov/40132142/
12. National Institutes of Health and National Center for Biotechnology Information. Polycystic ovary syndrome and acne. PubMed. https://pubmed.ncbi.nlm.nih.gov/21076799/
13. National Institutes of Health and National Center for Biotechnology Information. Prevalence of acne vulgaris among women with polycystic ovary syndrome: a systematic review and meta-analysis. PubMed. https://pubmed.ncbi.nlm.nih.gov/41089626/
14. National Institutes of Health and National Center for Biotechnology Information. Treatment of acne vulgaris during pregnancy and lactation: a narrative review. PubMed. https://pubmed.ncbi.nlm.nih.gov/36447117/
15. National Institutes of Health and National Center for Biotechnology Information. Inflammatory facial acne during uncomplicated pregnancy and post-partum in adult women: a preliminary hospital-based prospective observational study. PubMed. https://pubmed.ncbi.nlm.nih.gov/27102946/
16. National Institutes of Health and National Center for Biotechnology Information. Activity of the type 1 5 alpha-reductase exhibits regional differences in isolated sebaceous glands and whole skin. PubMed. https://pubmed.ncbi.nlm.nih.gov/7636302/
17. National Institutes of Health and National Center for Biotechnology Information. Propionibacterium acnes colonization in acne and nonacne. PubMed. https://pubmed.ncbi.nlm.nih.gov/9557227/
18. National Institutes of Health and National Center for Biotechnology Information. The immunogenetics of acne. PubMed. https://pubmed.ncbi.nlm.nih.gov/35286695/
19. National Institutes of Health and National Center for Biotechnology Information. Propionibacterium acnes and lipopolysaccharide induce the expression of antimicrobial peptides and proinflammatory cytokines/chemokines in human sebocytes. PubMed. https://pubmed.ncbi.nlm.nih.gov/16797202/
20. National Institutes of Health and National Center for Biotechnology Information. The role of inflammation in the pathology of acne. PubMed. https://pubmed.ncbi.nlm.nih.gov/24062871/
21. National Institutes of Health and National Center for Biotechnology Information. Review of the innate immune response in acne vulgaris: activation of Toll-like receptor 2 in acne triggers inflammatory cytokine responses. PubMed. https://pubmed.ncbi.nlm.nih.gov/16205063/
22. National Institutes of Health and National Center for Biotechnology Information. Association of different cell types and inflammation in early acne vulgaris. PubMed. https://pubmed.ncbi.nlm.nih.gov/38357543/
23. National Institutes of Health and National Center for Biotechnology Information. The effect of the menstrual cycle on acne. PubMed. https://pubmed.ncbi.nlm.nih.gov/11712049/
24. National Institutes of Health and National Center for Biotechnology Information. The association of acne and menstrual symptoms among young women (18-25 years) in Egypt: a population-based cross-sectional study. PubMed. https://pubmed.ncbi.nlm.nih.gov/32549185/
25. National Institutes of Health and National Center for Biotechnology Information. Correlation between endocrinological parameters and acne severity in adult women. PubMed. https://pubmed.ncbi.nlm.nih.gov/15202836/
26. National Institutes of Health and National Center for Biotechnology Information. Age-dependent endocrine disorders involved in the pathogenesis of refractory acne in women. PubMed. https://pubmed.ncbi.nlm.nih.gov/27840992/
27. National Institutes of Health and National Center for Biotechnology Information. Role of insulin, insulin-like growth factor-1, hyperglycaemic food and milk consumption in the pathogenesis of acne vulgaris. PubMed. https://pubmed.ncbi.nlm.nih.gov/19709092/
28. National Institutes of Health and National Center for Biotechnology Information. Correlation between serum levels of insulin-like growth factor 1, dehydroepiandrosterone sulfate, and dihydrotestosterone and acne lesion counts in adult women. PubMed. https://pubmed.ncbi.nlm.nih.gov/15781674/
29. National Institutes of Health and National Center for Biotechnology Information. Elevated serum insulin-like growth factor-1 (IGF-1) levels in women with postadolescent acne. PubMed. https://pubmed.ncbi.nlm.nih.gov/7608381/
30. National Institutes of Health and National Center for Biotechnology Information. Treatment of acne with oral contraceptives: criteria for pill selection. PubMed. https://pubmed.ncbi.nlm.nih.gov/11109151/
31. National Institutes of Health and National Center for Biotechnology Information. Hormonal contraceptives for acne management. PubMed. https://pubmed.ncbi.nlm.nih.gov/18338653/
32. National Institutes of Health and National Center for Biotechnology Information. Combined oral contraceptive pills for treatment of acne. PubMed. https://pubmed.ncbi.nlm.nih.gov/15266533/
33. National Institutes of Health and National Center for Biotechnology Information. Oral contraceptives as anti-androgenic treatment of acne. PubMed. https://pubmed.ncbi.nlm.nih.gov/12196847/
34. National Institutes of Health and National Center for Biotechnology Information. Progestins and acne vulgaris: a review. PubMed. https://pubmed.ncbi.nlm.nih.gov/30142728/
35. National Institutes of Health and National Center for Biotechnology Information. Hormonal treatment of acne: review of current best evidence. PubMed. https://pubmed.ncbi.nlm.nih.gov/15778821/
36. National Institutes of Health and National Center for Biotechnology Information. Hormonal therapies for acne: a comprehensive update. PubMed. https://pubmed.ncbi.nlm.nih.gov/39751745/
37. National Institutes of Health and National Center for Biotechnology Information. Hormonal treatment of acne in women. PubMed. https://pubmed.ncbi.nlm.nih.gov/20725580/
38. National Institutes of Health and National Center for Biotechnology Information. A review of hormone-based therapies to treat adult acne vulgaris in women. PubMed. https://pubmed.ncbi.nlm.nih.gov/28492054/
39. National Institutes of Health and National Center for Biotechnology Information. Hormonal therapies in the management of acne vulgaris. PubMed. https://pubmed.ncbi.nlm.nih.gov/35674767/
40. National Institutes of Health and National Center for Biotechnology Information. A randomized controlled trial of second- versus third-generation oral contraceptives. PubMed. https://pubmed.ncbi.nlm.nih.gov/12748463/
41. National Institutes of Health and National Center for Biotechnology Information. Effectiveness of spironolactone for women with acne. PubMed. https://pubmed.ncbi.nlm.nih.gov/37192767/
42. National Institutes of Health and National Center for Biotechnology Information. Spironolactone for acne: practical strategies for optimal clinical outcomes. PubMed. https://pubmed.ncbi.nlm.nih.gov/40875941/
43. National Institutes of Health and National Center for Biotechnology Information. Long-term use of spironolactone for acne in women: a case series of 403 patients. PubMed. https://pubmed.ncbi.nlm.nih.gov/33434594/
44. National Institutes of Health and National Center for Biotechnology Information. Use of spironolactone to treat acne in adolescent females. PubMed. https://pubmed.ncbi.nlm.nih.gov/33009838/
45. National Institutes of Health and National Center for Biotechnology Information. Long-term safety of spironolactone in acne. PubMed. https://pubmed.ncbi.nlm.nih.gov/12219252/
46. National Institutes of Health and National Center for Biotechnology Information. Isotretinoin for acne vulgaris: 10 years later: a safe and successful treatment. PubMed. https://pubmed.ncbi.nlm.nih.gov/8286227/
47. National Institutes of Health and National Center for Biotechnology Information. High-dose isotretinoin treatment and relapse rates. PubMed. https://pubmed.ncbi.nlm.nih.gov/24173086/
48. US Food and Drug Administration. Isotretinoin capsule information [Internet]. [cited 2026 Apr 27]. Available from: https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/isotretinoin-capsule-information
49. National Institutes of Health and National Center for Biotechnology Information. Analysis of common side effects of isotretinoin. PubMed. https://pubmed.ncbi.nlm.nih.gov/11606952/
50. National Institutes of Health and National Center for Biotechnology Information. Systematic review of low-dose isotretinoin. PubMed. https://pubmed.ncbi.nlm.nih.gov/33085149/
51. National Institutes of Health and National Center for Biotechnology Information. Topical retinoids in acne vulgaris: a systematic review. PubMed. https://pubmed.ncbi.nlm.nih.gov/30674002/
52. National Institutes of Health and National Center for Biotechnology Information. Topical retinoids in acne vulgaris: update on efficacy and safety. PubMed. https://pubmed.ncbi.nlm.nih.gov/18973403/
53. National Institutes of Health and National Center for Biotechnology Information. Why topical retinoids are mainstay of therapy for acne. PubMed. https://pubmed.ncbi.nlm.nih.gov/28585191/
54. National Institutes of Health and National Center for Biotechnology Information. Antibiotic resistance: shifting the paradigm in topical acne treatment. PubMed. https://pubmed.ncbi.nlm.nih.gov/25607703/
55. National Institutes of Health and National Center for Biotechnology Information. Antibiotics and antimicrobial resistance in acne. PubMed. https://pubmed.ncbi.nlm.nih.gov/36568833/
56. National Institutes of Health and National Center for Biotechnology Information. Antibiotic resistance in acne treatment. PubMed. https://pubmed.ncbi.nlm.nih.gov/28636689/
57. National Institutes of Health and National Center for Biotechnology Information. Antibiotic resistance in acne: changes, consequences and concerns. PubMed. https://pubmed.ncbi.nlm.nih.gov/32474948/
58. National Institutes of Health and National Center for Biotechnology Information. Antibiotic resistance in acne: mechanisms, complications and management. PubMed. https://pubmed.ncbi.nlm.nih.gov/32889707/
59. National Institutes of Health and National Center for Biotechnology Information. Systematic review of antibiotic resistance in acne. PubMed. https://pubmed.ncbi.nlm.nih.gov/26852728/
60. National Institutes of Health and National Center for Biotechnology Information. Approaches to limit systemic antibiotic use in acne. PubMed. https://pubmed.ncbi.nlm.nih.gov/30296534/
61. National Institute for Health and Care Excellence. Acne vulgaris: management. NICE Guidance NG198 [Internet]. [cited 2026 Apr 27]. Available from: https://www.nice.org.uk/guidance/ng198/
62. National Institutes of Health and National Center for Biotechnology Information. Treatment of acne in pregnancy. PubMed. https://pubmed.ncbi.nlm.nih.gov/26957383/
63. National Institutes of Health and National Center for Biotechnology Information. Management of acne in pregnancy. PubMed. https://pubmed.ncbi.nlm.nih.gov/38453786/
64. American College of Obstetricians and Gynecologists. Skin conditions during pregnancy [Internet]. [cited 2026 Apr 27]. Available from: https://www.acog.org/womens-health/faqs/skin-conditions-during-pregnancy
65. National Institutes of Health and National Center for Biotechnology Information. Acne and pregnancy: a clinical review and practice pearls. PubMed. https://pubmed.ncbi.nlm.nih.gov/38478945/
66. National Institutes of Health and National Center for Biotechnology Information. Adverse events related to topical drug treatments for acne vulgaris. PubMed. https://pubmed.ncbi.nlm.nih.gov/32347138/
67. National Institutes of Health and National Center for Biotechnology Information. The duration of acne treatment. PubMed. https://pubmed.ncbi.nlm.nih.gov/24918553/
68. Mayo Clinic. Acne: diagnosis and treatment [Internet]. [cited 2026 Apr 27]. Available from: https://www.mayoclinic.org/diseases-conditions/acne/diagnosis-treatment/drc-20368048
69. Mayo Clinic. Nonprescription acne treatment: which products work best [Internet]. [cited 2026 Apr 27]. Available from: https://www.mayoclinic.org/diseases-conditions/acne/in-depth/acne-treatments/art-20045814
70. National Institutes of Health and National Center for Biotechnology Information. Isotretinoin: dose, duration and relapse. PubMed. https://pubmed.ncbi.nlm.nih.gov/23013115/
71. National Institutes of Health and National Center for Biotechnology Information. Acne relapse rate and predictors following isotretinoin. PubMed. https://pubmed.ncbi.nlm.nih.gov/22795452/
72. National Institutes of Health and National Center for Biotechnology Information. Laser and light based treatments of acne. PubMed. https://pubmed.ncbi.nlm.nih.gov/23619435/
73. National Institutes of Health and National Center for Biotechnology Information. Established and emerging laser treatments for acne. PubMed. https://pubmed.ncbi.nlm.nih.gov/40575606/
74. National Institutes of Health and National Center for Biotechnology Information. The use of lasers and light devices in acne management. PubMed. https://pubmed.ncbi.nlm.nih.gov/34287769/
75. National Institutes of Health and National Center for Biotechnology Information. Emerging therapies for acne vulgaris. PubMed. https://pubmed.ncbi.nlm.nih.gov/29594974/
76. National Institutes of Health and National Center for Biotechnology Information. Laser and light-based therapy in treatment of acne vulgaris. PubMed. https://pubmed.ncbi.nlm.nih.gov/40550334/
77. National Institutes of Health and National Center for Biotechnology Information. Efficacy and tolerance of acne treatment using spironolactone and drospirenone contraceptive. PubMed. https://pubmed.ncbi.nlm.nih.gov/17964689/
78. National Institutes of Health and National Center for Biotechnology Information. Efficacy and safety of combined ethinyl estradiol/drospirenone in acne treatment. PubMed. https://pubmed.ncbi.nlm.nih.gov/21072290/
79. National Institutes of Health and National Center for Biotechnology Information. Diet and acne: a systematic review. PubMed. https://pubmed.ncbi.nlm.nih.gov/35373155/
80. National Institutes of Health and National Center for Biotechnology Information. Diet and acne: review of the evidence from 2009 to 2020. PubMed. https://pubmed.ncbi.nlm.nih.gov/33462816/
81. National Institutes of Health and National Center for Biotechnology Information. Dairy intake and acne vulgaris: a systematic review and meta-analysis of 78,529 participants. PubMed. https://pubmed.ncbi.nlm.nih.gov/30096883/
82. National Institutes of Health and National Center for Biotechnology Information. Sleep disturbances and acne: a comprehensive review. PubMed. https://pubmed.ncbi.nlm.nih.gov/41236274/
83. National Institutes of Health and National Center for Biotechnology Information. Double-blind, placebo-controlled study assessing the effect of chocolate consumption. PubMed. https://pubmed.ncbi.nlm.nih.gov/24847404/
84. National Institutes of Health and National Center for Biotechnology Information. The relationship between chocolate consumption and the severity of acne lesions. PubMed. https://pubmed.ncbi.nlm.nih.gov/38998499/
85. National Institutes of Health and National Center for Biotechnology Information. Dark chocolate exacerbates acne. PubMed. https://pubmed.ncbi.nlm.nih.gov/26711092/
86. National Institutes of Health and National Center for Biotechnology Information. The impact of psychological stress on acne. PubMed. https://pubmed.ncbi.nlm.nih.gov/28871928/
87. National Institutes of Health and National Center for Biotechnology Information. Study of psychological stress, sebum production and acne vulgaris in adolescents. PubMed. https://pubmed.ncbi.nlm.nih.gov/17340019/
88. National Institutes of Health and National Center for Biotechnology Information. The response of skin disease to stress: changes in the severity of acne vulgaris as affected by examination stress. PubMed. https://pubmed.ncbi.nlm.nih.gov/12873885/
89. Cleveland Clinic. Hormonal acne: what is it, treatment, causes and prevention [Internet]. [cited 2026 Apr 27]. Available from: https://my.clevelandclinic.org/health/diseases/21792-hormonal-acne
90. National Institutes of Health and National Center for Biotechnology Information. Sleep quality, circadian preferences, and mood among patients with acne vulgaris: a case-control study. PubMed. https://pubmed.ncbi.nlm.nih.gov/36650359/
91. National Institutes of Health and National Center for Biotechnology Information. Acne severity and sleep quality in adults. PubMed. https://pubmed.ncbi.nlm.nih.gov/33089183/
92. National Institutes of Health and National Center for Biotechnology Information. A cross-sectional study of body mass index and sleep quality as risk factors to severity of acne. PubMed. https://pubmed.ncbi.nlm.nih.gov/34580504/
93. American Academy of Dermatology. Skin care for acne-prone skin [Internet]. [cited 2026 Apr 27]. Available from: https://www.aad.org/public/diseases/acne/skin-care
94. American Academy of Dermatology. 10 skin care habits that can worsen acne [Internet]. [cited 2026 Apr 27]. Available from: https://www.aad.org/public/diseases/acne/skin-care/habits-stop
95. National Institutes of Health and National Center for Biotechnology Information. Cleansing and moisturising in acne patients. PubMed. https://pubmed.ncbi.nlm.nih.gov/19209947/
96. National Institutes of Health and National Center for Biotechnology Information. Expert consensus on holistic skin care routine. PubMed. https://pubmed.ncbi.nlm.nih.gov/36409588/
97. National Institutes of Health and National Center for Biotechnology Information. Skin diseases in elite athletes. PubMed. https://pubmed.ncbi.nlm.nih.gov/33975368/
98. National Institutes of Health and National Center for Biotechnology Information. The potential of exercise on lifestyle and skin function. PubMed. https://pubmed.ncbi.nlm.nih.gov/38483460/
99. National Institutes of Health and National Center for Biotechnology Information. Impact of lifestyle and dietary habits on the prevalence. PubMed. https://pubmed.ncbi.nlm.nih.gov/38681286/
100. National Institutes of Health and National Center for Biotechnology Information. A review of advancement on influencing factors of acne: an emphasis on environment characteristics. PubMed. https://pubmed.ncbi.nlm.nih.gov/33042936/
101. National Institutes of Health and National Center for Biotechnology Information. Sun exposure, a relevant exposome factor in acne patients and how photoprotection can improve outcomes. PubMed. https://pubmed.ncbi.nlm.nih.gov/36946555/
102. National Institutes of Health and National Center for Biotechnology Information. Association between exposure to ambient air pollution and occurrence of inflammatory acne. PubMed. https://pubmed.ncbi.nlm.nih.gov/34521361/
103. National Institutes of Health and National Center for Biotechnology Information. Long-term exposure to low levels of ambient UVB are associated with a decreased risk of moderate-to-severe acne. PubMed. https://pubmed.ncbi.nlm.nih.gov/36545686/
104. National Institutes of Health and National Center for Biotechnology Information. Exploring the potential of omega-3 fatty acids in acne patients. PubMed. https://pubmed.ncbi.nlm.nih.gov/38982829/
105. National Institutes of Health and National Center for Biotechnology Information. Effect of dietary supplementation with omega-3 fatty acid. PubMed. https://pubmed.ncbi.nlm.nih.gov/24553997/
106. National Institutes of Health and National Center for Biotechnology Information. Omega-3 versus omega-6 polyunsaturated fatty acids in the prevention and treatment of inflammatory skin diseases. PubMed. https://pubmed.ncbi.nlm.nih.gov/31979308/
107. National Institutes of Health and National Center for Biotechnology Information. Deficit of omega-3 fatty acids in acne patients. PubMed. https://pubmed.ncbi.nlm.nih.gov/38672789/
108. National Institutes of Health and National Center for Biotechnology Information. Treatment of acne with tea tree oil (melaleuca) products: a review of efficacy, tolerability and potential modes of action. PubMed. https://pubmed.ncbi.nlm.nih.gov/25465857/
109. National Institutes of Health and National Center for Biotechnology Information. Tea tree oil: properties and the therapeutic approach to acne; a review. PubMed. https://pubmed.ncbi.nlm.nih.gov/37371994/
110. National Institutes of Health and National Center for Biotechnology Information. Tea tree oil gel for mild to moderate acne; a 12 week uncontrolled, open-label phase II pilot study. PubMed. https://pubmed.ncbi.nlm.nih.gov/27000386/
111. National Institutes of Health and National Center for Biotechnology Information. The efficacy of 5% topical tea tree oil gel in mild to moderate acne vulgaris: a randomised, double-blind placebo-controlled study. PubMed. https://pubmed.ncbi.nlm.nih.gov/17314442/
112. National Institutes of Health and National Center for Biotechnology Information. Complementary therapies for acne vulgaris. PubMed. https://pubmed.ncbi.nlm.nih.gov/25597924/
113. National Institutes of Health and National Center for Biotechnology Information. Topical therapy of acne vulgaris using 2% tea lotion in comparison with 5% zinc sulphate solution. PubMed. https://pubmed.ncbi.nlm.nih.gov/19082228/
114. National Institutes of Health and National Center for Biotechnology Information. Essential oils in the treatment of various types of acne. PubMed. https://pubmed.ncbi.nlm.nih.gov/36616219/
115. National Institutes of Health and National Center for Biotechnology Information. Nature's remedy: a comprehensive review exploring herbal treatments and natural approaches for preventing acne vulgaris. PubMed. https://pubmed.ncbi.nlm.nih.gov/40662556/
116. National Institutes of Health and National Center for Biotechnology Information. Insulin-like growth factor-1 increases the expression of inflammatory biomarkers and sebum production in cultured sebocytes. PubMed. https://pubmed.ncbi.nlm.nih.gov/25318522/
117. National Institutes of Health and National Center for Biotechnology Information. Effect of insulin-like growth factor-1 deficiency or administration on the occurrence of acne. PubMed. https://pubmed.ncbi.nlm.nih.gov/21054577/
118. JAMA Network. Correlation between serum levels of insulin-like growth factor 1, dehydroepiandrosterone sulfate, and dihydrotestosterone and acne lesion counts. JAMA Dermatology. https://jamanetwork.com/journals/jamadermatology/fullarticle/393279
119. National Institutes of Health and National Center for Biotechnology Information. Propionibacterium acnes strain populations in the human skin microbiome associated with acne. PubMed. https://pubmed.ncbi.nlm.nih.gov/23337890/
120. National Institutes of Health and National Center for Biotechnology Information. Acne, the skin microbiome, and antibiotic treatment. PubMed. https://pubmed.ncbi.nlm.nih.gov/30632097/
121. National Institutes of Health and National Center for Biotechnology Information. The microbiome and acne: perspectives for treatment. PubMed. https://pubmed.ncbi.nlm.nih.gov/38183614/
122. National Institutes of Health and National Center for Biotechnology Information. Staphylococcus epidermidis in the human skin microbiome mediates fermentation to inhibit the growth of Propionibacterium acnes. PubMed. https://pubmed.ncbi.nlm.nih.gov/24265031/
123. National Institutes of Health and National Center for Biotechnology Information. Skin microbiome and acne vulgaris: Staphylococcus, a new actor in acne. PubMed. https://pubmed.ncbi.nlm.nih.gov/28094874/
124. National Institutes of Health and National Center for Biotechnology Information. The role of the skin microbiome in acne: challenges and future therapeutic opportunities. PubMed. https://pubmed.ncbi.nlm.nih.gov/39518974/
125. National Institutes of Health and National Center for Biotechnology Information. Guidelines of care for the management of acne vulgaris. PubMed. https://pubmed.ncbi.nlm.nih.gov/38300170/
126. National Institutes of Health and National Center for Biotechnology Information. A systematic review of the evidence for 'myths and misconceptions' in acne management: diet, face-washing and sunlight. PubMed. https://pubmed.ncbi.nlm.nih.gov/15644386/
127. National Institutes of Health and National Center for Biotechnology Information. Management of acne vulgaris: a review. PubMed. https://pubmed.ncbi.nlm.nih.gov/34812859/
128. Cleveland Clinic. Acne: types, causes, treatment and prevention [Internet]. [cited 2026 Apr 27]. Available from: https://my.clevelandclinic.org/health/diseases/12233-acne
129. Mayo Clinic. Polycystic ovary syndrome (PCOS): symptoms and causes [Internet]. [cited 2026 Apr 27]. Available from: https://www.mayoclinic.org/diseases-conditions/pcos/symptoms-causes/syc-20353439